Are P2Y12 inhibitors superior to aspirin for long-term secondary prevention of cardiovascular disease?

被引：1
作者：
Carlin, Stephanie [1 ,2 ]
Eikelboom, John [1 ,2 ,3 ]
机构：
[1] Hamilton Gen Hosp, Thrombosis Serv, Hamilton, ON, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
[3] Populat Hlth Res Inst, Hamilton, ON, Canada
来源：
EXPERT REVIEW OF CARDIOVASCULAR THERAPY | 2023年 / 21卷 / 05期
关键词：
cardiovascular disease; secondary prevention; antiplatelet agents; aspirin; P2Y12 receptor antagonists; PERCUTANEOUS CORONARY INTERVENTION; DUAL ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; CLOPIDOGREL; TICAGRELOR; STROKE; MONOTHERAPY; PRASUGREL; RISK;
D O I：
10.1080/14779072.2023.2199155
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：305 / 309
页数：5
相关论文
共 30 条
  • [1] 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
    Aboyans, Victor
    Ricco, Jean-Baptiste
    Bartelink, Marie-Louise E. L.
    Bjoerck, Martin
    Brodmann, Marianne
    Cohnert, Tina
    Collet, Jean-Philippe
    Czerny, Martin
    De Carlo, Marco
    Debus, Sebastian
    Espinola-Klein, Christine
    Kahan, Thomas
    Kownator, Serge
    Mazzolai, Lucia
    Naylor, A. Ross
    Roffi, Marco
    Roether, Joachim
    Sprynger, Muriel
    Tendera, Michal
    Tepe, Gunnar
    Venermo, Maarit
    Vlachopoulos, Charalambos
    Desormais, Ileana
    [J]. KARDIOLOGIA POLSKA, 2017, 75 (11) : 1065 - 1160
  • [2] Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors
    Adamski, Piotr
    Kozinski, Marek
    Ostrowska, Malgorzata
    Fabiszak, Tomasz
    Navarese, Eliano Pio
    Paciorek, Przemyslaw
    Grzesk, Grzegorz
    Kubica, Jacek
    [J]. THROMBOSIS AND HAEMOSTASIS, 2014, 112 (02) : 224 - 242
  • [3] Aggarwal D, 2022, EUR HEART J OPEN, P2, DOI DOI 10.1093/EHJOPEN/OEAC019
  • [4] P2Y12 Inhibitors versus Aspirin Monotherapy for Long-term Secondary Prevention of Atherosclerotic Cardiovascular Disease Events: A Systematic Review and Meta-analysis
    Al-Abdouh, Ahmad
    Abusnina, Waiel
    Mhanna, Mohammed
    Radideh, Qais
    Alzu'bi, Hossam
    Abu Rmilah, Anan
    Jabri, Ahmad
    Barbarawi, Mahmoud
    Obeidat, Khaldun
    Alabduh, Taqwa
    Michos, Erin D.
    Alnabelsi, Talal
    Paul, Timir K.
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (10)
  • [5] P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
    Ando, Giuseppe
    De Santis, Giulia Azzurra
    Greco, Antonio
    Pistelli, Lorenzo
    Francaviglia, Bruno
    Capodanno, Davide
    De Caterina, Raffaele
    Capranzano, Piera
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (22) : 2239 - 2249
  • [6] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [7] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    Bhatt, DL
    Fox, KAA
    Hacke, W
    Berger, PB
    Black, HR
    Boden, WE
    Cacoub, P
    Cohen, EA
    Creager, MA
    Easton, JD
    Flather, MD
    Haffner, SM
    Hamm, CW
    Hankey, GJ
    Johnston, SC
    Mak, KH
    Mas, JL
    Montalescot, G
    Pearson, TA
    Steg, PG
    Steinhubl, SR
    Weber, MA
    Brennan, DM
    Fabry-Ribaudo, L
    Booth, J
    Topol, EJ
    Frye, RL
    Amarenco, P
    Brass, LM
    Buyse, M
    Cohen, LS
    DeMets, DL
    Fuster, V
    Hart, RG
    Marler, JR
    McCarthy, C
    Schoemig, A
    Lincoff, AM
    Brener, SJ
    Sila, CA
    Albuquerque, A
    Aroutiounov, G
    Artemiev, D
    Atkeson, BG
    Bartel, T
    Basart, DCG
    Lima, AB
    Belli, G
    Bordalo e Sa, AL
    Bosch, X
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) : 1706 - 1717
  • [8] Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
    Chen, ZM
    Jiang, LX
    Chen, YP
    Xie, JX
    Pan, HC
    Peto, R
    Collins, R
    Liu, LS
    Chen, ZM
    Liu, LS
    Collins, R
    Jiang, LX
    Chen, YP
    Xie, JX
    Pan, HC
    Peto, R
    Cai, NS
    Chen, YZ
    Cui, JJ
    Dai, GZ
    Feng, JZ
    Fu, SY
    Gent, M
    Gong, LS
    Hu, DY
    Huang, DJ
    Huang, J
    Huang, TG
    Huang, ZW
    Hui, RT
    Jiang, BQ
    Li, DY
    Li, SM
    Li, TD
    Li, YQ
    Li, ZQ
    Liu, YH
    Meng, QY
    Qian, TJ
    San, J
    Tao, SQ
    Wang, DW
    Wang, LH
    Wang, W
    Wu, HA
    Xi, WH
    Xu, CB
    Yang, DC
    Yang, XF
    Yin, JQ
    [J]. LANCET, 2005, 366 (9497) : 1607 - 1621
  • [9] Monotherapy with a P2Y 12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis
    Chiarito, Mauro
    Sanz-Sanchez, Jorge
    Cannata, Francesco
    Cao, Davide
    Sturla, Matteo
    Panico, Cristina
    Godino, Cosmo
    Regazzoli, Damiano
    Reimers, Bernhard
    De Caterina, Raffaele
    Condorelli, Gianluigi
    Ferrante, Giuseppe
    Stefanini, Giulio G.
    [J]. LANCET, 2020, 395 (10235) : 1487 - 1495
  • [10] Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
    Franzone, Anna
    McFadden, Eugene
    Leonardi, Sergio
    Piccolo, Raffaele
    Vranckx, Pascal
    Serruys, Patrick W.
    Benit, Edouard
    Liebetrau, Christoph
    Janssens, Luc
    Ferrario, Maurizio
    Zurakowski, Aleksander
    Diletti, Roberto
    Dominici, Marcello
    Huber, Kurt
    Slagboom, Ton
    Buszman, Pawel
    Bolognese, Leonardo
    Tumscitz, Carlo
    Bryniarski, Krzysztof
    Aminian, Adel
    Vrolix, Mathias
    Petrov, Ivo
    Garg, Scot
    Naber, Christoph
    Prokopczuk, Janusz
    Hamm, Christian
    Steg, Philippe Gabriel
    Heg, Dik
    Juni, Peter
    Windecker, Stephan
    Valgimigli, Marco
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (18) : 2223 - 2234
123